Targeted cancer therapy based on blocking the expression of genes and small doses of oxaliplatin.
Poster Apr 01, 2014
Bavykin A.S.1, Korotaeva A.A.1, Poyarkov S.V.2, Syrtsev A.V.1, Karpukhin A.V.1
Results. We found that colon cancer cells HCT-116, when exposed to low concentrations of oxaliplatin (5 and 10mkM) showed the the same survival rate as for the untreated cells, however their expression patterns were different. We examined the panel of genes with various functions in the presence of small dozes of oxaliplatin and picked up those, that displayed marked overexpression and were depended both on the oxaliplatin dose escalation and the incubation period. These genes belong to the family of inhibitors of apoptosis and associated with the caspase cascade. Shutting down the expression of these genes was performed using short interfering RNAs (siRNAs), attached to the liposome particles. These ultra – small molecules can suppress synthesis of desired proteins at the level of messenger RNA of Birc3 and Birc7 genes. Due to the ultra small size, and low concentration, that is sufficient enough to inhibit protein synthesis at an early stage. Thus siRNA have considerable advantages compared with targeted antibodies.
Conclusion. Identified target genes Birc3 and Birc7 display specific response to oxaliplatin treatment. Joint inhibiting the synthesis of these genes resulted in virtually complete (85%, p<0,05) suppression of the viability of cancer cells and increased (7-fold) sensitivity of cancer cells to low doses of oxaliplatin.
Is Oxford Nanopore Technology Ready for Clinical Diagnostics?Poster
Our objective is to validate diagnostic services using Oxford Nanopore’s Minion in the first instance and to evaluate the cost and performance compared to existing sequencing technology in areas such as tumour DNA sequencing (and circulating tumour DNA), virology, microbiology, genetics and HLA-typing.READ MORE
Combining a Real-Time In Vitro Cell Viability Assay and RNA Extraction from the Same 3D SpheroidsPoster
We report here the results of using a novel small molecule probe that viable cells convert into a substrate for a shrimp-derived luciferase to generate a signal proportional to the number of viable cells.READ MORE
Performance of the D5000 and High Sensitivity D5000 ScreenTape Assays for the 4200 TapeStation SystemPoster
Here, we focus on quantification, sizing, and sensitivity of both D5000 ScreenTape assays.READ MORE